Copyright
©The Author(s) 2021.
World J Diabetes. Aug 15, 2021; 12(8): 1248-1254
Published online Aug 15, 2021. doi: 10.4239/wjd.v12.i8.1248
Published online Aug 15, 2021. doi: 10.4239/wjd.v12.i8.1248
IBD medication | Glycaemic effect |
Aminosalicylates | Potential hypoglycaemic effect |
Corticosteroids | Significant cause of hyperglycaemia |
Thiopurines | Possible reduced insulin resistance |
Infliximab | Appears to reduce insulin resistance |
Adalimumab | Potential hypoglycaemic effect |
- Citation: Bower JAJ, O'Flynn L, Kakad R, Aldulaimi D. Effect of inflammatory bowel disease treatments on patients with diabetes mellitus. World J Diabetes 2021; 12(8): 1248-1254
- URL: https://www.wjgnet.com/1948-9358/full/v12/i8/1248.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i8.1248